Defibtech
Private Company
Total funding raised: $35M
Overview
Defibtech is a privately held medical device manufacturer with a core mission to enhance survival from sudden cardiac arrest through innovative, accessible technology. The company operates in two primary segments: public-access AEDs for bystander use and professional-grade ACC devices for emergency personnel. With a long-standing presence since 1999, Defibtech has established itself as a key player in the cardiovascular resuscitation equipment market, leveraging a direct and distributor-based sales model. The company's strategy centers on product reliability, ease of use, and serving both the public safety and professional EMS markets.
Technology Platform
Platform for automated external defibrillation (AED) and automated mechanical chest compression (ACC) devices, focused on user-friendly design and reliability for both public and professional use.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Defibtech competes in the AED market against giants like Philips (HeartStart), ZOLL (AED Plus), and Stryker (LIFEPAK). In the mechanical CPR segment, competitors include ZOLL (AutoPulse) and Physio-Control (LUCAS). The landscape is characterized by strong brand loyalty, continuous incremental innovation, and pressure on pricing.